"We are one of the premier clinical research sites in the country, currently specializing in NAFLD, NASH, and other liver disease research studies."

During the past decade, Covenant Metabolic Specialists, LLC conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 1 clinical trials were completed. i.e. 6.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Covenant Metabolic Specialists, LLC" #1 sponsor was "Madrigal Pharmaceuticals, Inc." with 3 trials, followed by "Altimmune, Inc." with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Hepion Pharmaceuticals, Inc." with 2 trials sponsored and "CymaBay Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Covenant Metabolic Specialists, LLC" #1 collaborator was "Novo Nordisk A/S" with 1 trials as a collaborator and "Zealand Pharma" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Covenant Metabolic Specialists, LLC" are "Non-Alcoholic Fatty Liver Disease" (4 trials), "Fibrosis, Liver" (2 trials), "NASH - Nonalcoholic Steatohepatitis" (2 trials), "Primary Biliary Cholangitis" (2 trials) and "Healthy" (1 trials). Many other conditions were trialed in "Covenant Metabolic Specialists, LLC" in a lesser frequency.

Most popular intervention types in "Covenant Metabolic Specialists, LLC" are "Drug" (16 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "ALT-801" (2 trials), "BI 456906" (2 trials), "Resmetirom" (2 trials) and "BFKB8488A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Covenant Metabolic Specialists, LLC" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Covenant Metabolic Specialists, LLC". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Covenant Metabolic Specialists, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Covenant Metabolic Specialists, LLC, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".